AEGiS-PRn: New England Journal of Medicine Publishes Landmark AIDS Studies: In Studies, Crixivan(R) in Triple Therapy Kept HIV Below Detection in Most Patients; Fewer AIDS-Related Illnesses and Deaths Observed -- Most People with HIV Still Not Taking 3-Drug `Cocktail'

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

New England Journal of Medicine Publishes Landmark AIDS Studies: In Studies, Crixivan(R) in Triple Therapy Kept HIV Below Detection in Most Patients; Fewer AIDS-Related Illnesses and Deaths Observed -- Most People with HIV Still Not Taking 3-Drug `Cocktail'

PR Newswire, 810 Seventh Avenue, New York, NY 10019 - Wednesday September 10 5:00 PM EDT

WEST POINT, Pa., Sept. 10 /PRNewswire/ -- The New England Journal of Medicine today published studies that showed that Merck's (NYSE:MRK) protease inhibitor Crixivan(R) (indinavir sulfate) taken with two other AIDS drugs reduced HIV in the blood to undetectable levels (less than 500 copies vRNA/mL) for one year in most patients, with fewer patients taking Crixivan progressing to AIDS-defining illnesses or death than patients taking therapy without Crixivan.

Copyright (c) 1997/PR NewsWire. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, PR Newswire, 810 Seventh Avenue, New York, NY 10019.
970910
PR970904

Copyright © 1997 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .